Decentralized Clinical Trials: Are they here to stay? Decentralized clinical trials (DCTs) have been central to the continuation of vital clinical studies throughout the COVID-19 pandemic. Previously the uptake of decentralized models has been slow, but the pandemic changed this. There is now consensus among industry leaders that DCTs are here to stay and may have a central role in advancing research especially
Cromos Pharma on the advantages of conducting clinical trials in Poland Cromos Pharma has been successfully delivering full service clinical research solutions in Poland since 2015. Poland is one of our key locations across Central and Eastern Europe for carrying out clinical trials. Our team has specialist knowledge of the country and the wider region to ensure rapid patient recruitment, expedited study timelines and high quality
Cromos Pharma celebrates Cancer Survivors Month The number of cancer survivors is rising worldwide, due to advances in early detection and treatment as well as the aging of the world’s population. In 2018, there were approximately 43.8 million cancer survivors diagnosed within the previous 5 years. This June Cromos Pharma is celebrating #CancerSurvivorMonth by remembering all those who are currently going through their cancer journey
